News Announcement

Aurobindo Pharma: Intimation Of Record Date Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.

Further to our letter dated January 31 2023 intimating the date of Board Meeting to be held on February 9 2023 inter alia to consider unaudited financial results for the quarter and nine months period ended December 31 2022 and interim dividend for the FY 2022-23 and pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we hereby inform that the interim dividend if declared shall be paid to the equity shareholders of the Company whose names appear on the Register of Members as on February 17 2023 which is the Record Date fixed for this purpose.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds